S&P 500   3,682.61 (+0.37%)
DOW   30,109.86 (+0.76%)
QQQ   304.81 (+0.32%)
AAPL   123.07 (+-0.01%)
MSFT   214.98 (-0.18%)
FB   282.99 (-1.58%)
GOOGL   1,825.29 (+0.02%)
AMZN   3,197.05 (-0.20%)
TSLA   593.62 (+4.36%)
NVDA   536.65 (-0.95%)
BABA   267.30 (+2.29%)
CGC   28.93 (+2.66%)
GE   10.62 (+1.82%)
MU   70.44 (+1.92%)
AMD   92.67 (-1.14%)
T   29.15 (+0.21%)
NIO   46.20 (-3.71%)
F   9.23 (+0.33%)
ACB   11.30 (+3.20%)
NFLX   497.53 (-1.16%)
BA   238.53 (+6.56%)
GILD   60.79 (-0.56%)
DIS   153.50 (-0.07%)
S&P 500   3,682.61 (+0.37%)
DOW   30,109.86 (+0.76%)
QQQ   304.81 (+0.32%)
AAPL   123.07 (+-0.01%)
MSFT   214.98 (-0.18%)
FB   282.99 (-1.58%)
GOOGL   1,825.29 (+0.02%)
AMZN   3,197.05 (-0.20%)
TSLA   593.62 (+4.36%)
NVDA   536.65 (-0.95%)
BABA   267.30 (+2.29%)
CGC   28.93 (+2.66%)
GE   10.62 (+1.82%)
MU   70.44 (+1.92%)
AMD   92.67 (-1.14%)
T   29.15 (+0.21%)
NIO   46.20 (-3.71%)
F   9.23 (+0.33%)
ACB   11.30 (+3.20%)
NFLX   497.53 (-1.16%)
BA   238.53 (+6.56%)
GILD   60.79 (-0.56%)
DIS   153.50 (-0.07%)
S&P 500   3,682.61 (+0.37%)
DOW   30,109.86 (+0.76%)
QQQ   304.81 (+0.32%)
AAPL   123.07 (+-0.01%)
MSFT   214.98 (-0.18%)
FB   282.99 (-1.58%)
GOOGL   1,825.29 (+0.02%)
AMZN   3,197.05 (-0.20%)
TSLA   593.62 (+4.36%)
NVDA   536.65 (-0.95%)
BABA   267.30 (+2.29%)
CGC   28.93 (+2.66%)
GE   10.62 (+1.82%)
MU   70.44 (+1.92%)
AMD   92.67 (-1.14%)
T   29.15 (+0.21%)
NIO   46.20 (-3.71%)
F   9.23 (+0.33%)
ACB   11.30 (+3.20%)
NFLX   497.53 (-1.16%)
BA   238.53 (+6.56%)
GILD   60.79 (-0.56%)
DIS   153.50 (-0.07%)
S&P 500   3,682.61 (+0.37%)
DOW   30,109.86 (+0.76%)
QQQ   304.81 (+0.32%)
AAPL   123.07 (+-0.01%)
MSFT   214.98 (-0.18%)
FB   282.99 (-1.58%)
GOOGL   1,825.29 (+0.02%)
AMZN   3,197.05 (-0.20%)
TSLA   593.62 (+4.36%)
NVDA   536.65 (-0.95%)
BABA   267.30 (+2.29%)
CGC   28.93 (+2.66%)
GE   10.62 (+1.82%)
MU   70.44 (+1.92%)
AMD   92.67 (-1.14%)
T   29.15 (+0.21%)
NIO   46.20 (-3.71%)
F   9.23 (+0.33%)
ACB   11.30 (+3.20%)
NFLX   497.53 (-1.16%)
BA   238.53 (+6.56%)
GILD   60.79 (-0.56%)
DIS   153.50 (-0.07%)
Log in
CNSX:MPX

MPX Bioceutical Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MPX Bioceutical Corporation is a multinational diversified cannabis company focused on the medical and adult use cannabis markets. The company has a growing presence in the U.S. with imminent plans for ten dispensaries and four production facilities in four states. It also has a production facility under construction in Canada as well as a pending licence application to Health Canada.

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.54 out of 5 stars


Industry, Sector and Symbol

Stock Exchange CNSX
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryCannabis
SectorMedical
Current SymbolCNSX:MPX
Previous Symbol
CUSIPN/A
CIKN/A
Webcanadianbioceutical.com
Phone+1-416-840-3725
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableOptionable

Receive MPX News and Ratings via Email

Sign-up to receive the latest news and ratings for MPX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MPX Bioceutical (CNSX:MPX) Frequently Asked Questions

What stocks does MarketBeat like better than MPX Bioceutical?

Wall Street analysts have given MPX Bioceutical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MPX Bioceutical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of MPX Bioceutical's key competitors?

Some companies that are related to MPX Bioceutical include Canopy Growth (WEED), Canopy Growth (CGC), Innovative Industrial Properties (IIPR), MedReleaf Corp. (LEAF.TO) (LEAF), GrowGeneration (GRWG), OrganiGram Holdings Inc. (OGI.TO) (OGI), Emblem (EMC), ICC Labs Inc. (ICC.V) (ICC), 22nd Century Group (XXII), Bioventix PLC (BVXP.L) (BVXP), KushCo (KSHB), General Cannabis (CANN), Terra Tech (TRTC), Grow Capital (GRWC) and Leafbuyer Technologies (LBUY).
View all competitors.

What other stocks do shareholders of MPX Bioceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MPX Bioceutical investors own include CalAmp (CAMP), Canopy Growth (CGC), Aurora Cannabis Inc. (ACB.TO) (ACB), Aurora Cannabis (ACBFF), Nemaska Lithium Inc. (NMX.TO) (NMX), Terra Tech (TRTC), Village Farms International, Inc. (VFF.TO) (VFF), VIVO Cannabis Inc. (ABCN.V) (ABCN), AcelRx Pharmaceuticals (ACRX) and Allena Pharmaceuticals (ALNA).

What is MPX Bioceutical's stock symbol?

MPX Bioceutical trades on the CNSX under the ticker symbol "MPX."

What is MPX Bioceutical's official website?

The official website for MPX Bioceutical is canadianbioceutical.com.

How can I contact MPX Bioceutical?

MPX Bioceutical's mailing address is 5255 Yonge St Suite 701, NORTH YORK, ON M2N 6P4, Canada. The company can be reached via phone at +1-416-840-3725.

This page was last updated on 12/3/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.